Substantial elevation in circulatory TSP1—up to a thousand-fold higher—has been recognized as a biomarker in multiple pathologic conditions, including coronary artery disease (CAD), pulmonary arterial hypertension (PAH), type II diabetes, and cardiac allografts [2,3,4]. This evidence concerns the gene THBS1 and coronary artery disorder.